MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The analysis of cognitive impairment associated with Parkinson’s disease

Z. Mao, X. Xue (Hubei, China)

Meeting: 2018 International Congress

Abstract Number: 1220

Keywords: Parkinsonism dementia complex(PDC)

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Cognition

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: The study was to investigate the traits, the related factors and the impact on quality of life of cognitive impairment associated with Parkinson’s disease.

Background: Parkinson’s disease is a kind of chronic neurodegenerative diseases. Not only serious motor dysfunction, there is very prominent cognitive dysfunction which seriously affecting the quality of life of the patients.

Methods: One hundred idiopathic PD patients from Tongji Hospital were recruited. The H-Y score, the UPDRS-III Scale, the CDR, the MMSE, the MoCA, HAMA, HAMD, ESS, ADL and PDQL-39 questionnaire and the table of drug usage were used for assessment. These recorded the course of disease, age of onset, severity of illness, dopaminergic drug usage and cognitive status. Moreover, we analyzed the correlation between cognitive impairment in Parkinson’s disease and duration of disease, severity of illness, education and drug usage.

Results: (1) 47 cases of PD patients had cognitive impairment (PD-CI group), accounting for 47%, and 53 cases consisted of non-cognitive impairment group (PD-NCI group), which made up 53%; (2)The MoCA scores and the MMSE scores of PD-CI group were (19.93 ± 3.50) and (22.93 ± 2.90), which of PD-NCI group were (26.74 ± 1.48) and (28.74 ± 1.36), which had a statistical significance. (3)The scores which concluded visuospatial , executive ability, naming, attention and calculation ability, language, abstract thinking, delayed memory, orientation of PD-CI group were lower than the PD-NCI group. In addition, the scores of attention, calculation ability, memory latency, visuospatial and executive ability significantly were obviously lower in the PD-CI group. (4) Multiple linear regression found that cognitive impairment in Parkinson’s disease were negatively correlated with scores age, age of onset, UPDRS-III score, H-Y score ,HAMA score and HAMD score, while positively correlated with education time and ADL,of which education time and H-Y scores had the most significant impact on cognitive ability . However, it had no relevance of the duration of disease. (5) Comparison of activities of daily living and quality of life: The scores of UPDRS-III, ADL and PDQL-39 of PD-NCI group were higher than which of the PD-CI group, which also had statistical significance.

Conclusions: PD-CI had a significant morbidity, the major affected factors of which were the attention of the calculation ability, delayed memory, visuospatial and executive ability. Besides, PD-CI was related to the severity of the disease and the education time, which seriously affected the quality of life of patients.

To cite this abstract in AMA style:

Z. Mao, X. Xue. The analysis of cognitive impairment associated with Parkinson’s disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/the-analysis-of-cognitive-impairment-associated-with-parkinsons-disease/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-analysis-of-cognitive-impairment-associated-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley